At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions
In Brief
A Phase 3 clinical trial evaluating Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation and Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Express) placement for Coronary Artery Disease. Completed, enrolled 1,264 participants across 90 sites in 4 countries.
Detailed Summary
The purpose of the TAXUS PERSEUS Workhorse trial is to evaluate the safety and efficacy of the next-generation Boston Scientific TAXUS paclitaxel-eluting coronary stent system (TAXUS® ElementTM) for the treatment of de novo atherosclerotic lesions of up to 28 mm in length in native coronary arteries of 2.75 mm to 4.0 mm diameter.
Study Details
Timeline
Interventions
TAXUS Element stent placement
TAXUS Express Stent Implant